A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
05/2011
05/19/2011	US20110118308 Crystals of laquinimod sodium, and process for the manufacture thereof
05/19/2011	US20110118305 Compounds
05/19/2011	US20110118281 Compounds for inflammation and immune-related uses
05/19/2011	US20110118273 Pyrrolo-pyridine, pyrrolo-pyrimidine and related heterocyclic compounds
05/19/2011	US20110118269 Fused pyrazine compounds as their salts, useful for the treatment of degenerative and inflammatory diseases
05/19/2011	US20110118257 Novel kinase modulators
05/19/2011	US20110118248 Heteroaryl sulfonamides and CCR2/CCR9
05/19/2011	US20110118246 Novel Compounds
05/19/2011	US20110118245 Raf kinase modulator compounds and methods of use thereof
05/19/2011	US20110118235 Substituted benzoazepines as toll-like receptor modulators
05/19/2011	US20110118233 Certain Substituted Amides, Method of Making, and Method of Use Thereof
05/19/2011	US20110118210 Aminopropanol derivatives
05/19/2011	US20110118208 Thiazolyl-Dihydro-Indazoles
05/19/2011	US20110118201 Glutathione production enhancer, prophylactic/therapeutic agent for diseases caused by glutathione deficiency, and food, beverage and feed
05/19/2011	US20110117204 Immunologically active compositions
05/19/2011	US20110117191 Mixture of substances on the basis of a mixture of essential oils and use
05/19/2011	US20110117137 Tapasin augmentation for enhanced immune response
05/19/2011	US20110117136 Dehydroepiandrosterone production promoter and use thereof
05/19/2011	US20110117135 Method of Forming Dendritic Cells from Embryonic Stem Cells
05/19/2011	US20110117133 Novel Recombinant BCG Tuberculosis Vaccine Designed to Elicit Immune Responses to Mycobacterium Tuberculosis in all Physiological Stages of Infection and Disease
05/19/2011	US20110117132 Mutated salmonella typhi strain and use thereof in a vaccine
05/19/2011	US20110117131 Production of OspA for Lyme Disease Control
05/19/2011	US20110117130 Method of diagnosing and treating Ehrlichia
05/19/2011	US20110117129 Vaccine Against Highly Pathogenic Porcine Reproductive and Respiratory Syndrome (HP PRRS)
05/19/2011	US20110117128 Compositions that Include Hemagglutinin, Methods of Making and Methods of Use Thereof
05/19/2011	US20110117127 Analysis of dna by means of capillary electrophoresis
05/19/2011	US20110117125 Compositions and methods for the delivery of nucleic acids
05/19/2011	US20110117124 Enhancement of transgene expression from viral-based vaccine vectors by expression of suppressors of the type i interferon response
05/19/2011	US20110117123 Multivalent Vaccine Composition With Mixed Carrier
05/19/2011	US20110117120 Plasmodium falciparum HLA class I restricted T-cell epitopes
05/19/2011	US20110117118 Molecules, compositions, methods and kits for applications associated with flaviviruses
05/19/2011	US20110117116 Nucleic acids encoding a house dust mite allergen, der p iii, and uses therefor
05/19/2011	US20110117115 Method and vaccine comprising copolymer 1 for treatment of psychiatric disorders
05/19/2011	US20110117113 Immunoglobulin single variable domain directed against human cxcr4 and other cell associated proteins and methods to generate them
05/19/2011	US20110117105 Method of treating immune disease using b-cell antibodies
05/19/2011	US20110117103 Anti-sweat antigen monoclonal antibody
05/19/2011	US20110117093 Antibodies that immunospecifically bind to b lymphocyte stimulator protein
05/19/2011	US20110117091 Humanization of rabbit antibodies using a universal antibody framework
05/19/2011	US20110117089 BCR-Complex-Specific Antibodies And Methods Of Using Same
05/19/2011	US20110117084 Vandetanib derivatives
05/19/2011	US20110117082 Soluble Tumor Necrosis Factor Receptor Mutant
05/19/2011	US20110117077 Nutritional composition for infants delivered via caesarean section
05/19/2011	US20110117073 Protein Kinase Conjugates and Inhibitors
05/19/2011	US20110117072 Hyperactive variants of the transposase protein of the transposon system sleeping beauty
05/19/2011	US20110117051 Method for inducing and accelerating cells
05/19/2011	US20110117050 Methods for Providing a System of Care for an Oxazaphosphorine Drug Regimen
05/19/2011	US20110117021 Fully human anti-vap-1 monoclonal antibodies
05/19/2011	US20110117015 Diagnostic Agents Selective Against Metalloproteases
05/19/2011	US20110117009 Drug conjugates with polyglycerols
05/19/2011	DE102010048788A1 Transdermal system, useful e.g. as monotherapy for indicating e.g. multiple sclerosis, comprises immunomodulator as active agent and active agent-impermeable removable protective coating, adhesive layer and active agent permeable membrane
05/19/2011	DE102009053089A1 Stoffgemisch auf Basis einer Misching von ätherischen Ölen und Verwendung Mixture based on a Misching of essential oils and use
05/19/2011	CA2817495A1 Compositions, methods and uses for stimulating immune responses
05/19/2011	CA2781049A1 (poly)-glycerolphosphate-based anti-gram positive bacterial vaccine
05/19/2011	CA2780723A1 Novel double-stranded ribonucleic acids with rugged physico-chemical structure and highly specific biologic activity
05/19/2011	CA2780225A1 Aloe vera sprout concentrate or extract having superior skin cell promotion, antioxidant, and anti-allergy effects
05/19/2011	CA2780066A1 Non-dna base-containing polynucleotide compositions and their use for the modulation of immune responses
05/19/2011	CA2778175A1 8-azabicyclo[3.2.1]octane-8-carboxamide derivative
05/19/2011	CA2778174A1 Tricyclic pyrazol amine derivatives
05/18/2011	EP2322644A1 Methods for producing modified glycoproteins
05/18/2011	EP2322615A1 Use of unmethylated CpG oligonucleotides for the treatment of allergy
05/18/2011	EP2322603A1 Compositions and methods for priming monocytic dendritic cells and T cells for Th1 response
05/18/2011	EP2322557A2 Compositions and methods for treating proliferative disorders
05/18/2011	EP2322553A2 Interleukin-17F antibodies and other IL-17F signaling antagonists and uses therefor
05/18/2011	EP2322552A2 IL-1beta binding antibodies and fragments thereof
05/18/2011	EP2322551A2 Compositions comprising Anti-IGF-1R Antibodies and Methods for their Production
05/18/2011	EP2322550A1 Compositions comprising anti-IGF-1R Antibodies and Methods for obtaining said Antibodies
05/18/2011	EP2322521A1 Heteroaryl compounds useful as inhibitors of GSK-3
05/18/2011	EP2322229A2 Remodelling and glycoconjugation of Granulocyte Colony Stimulating Factor (G-CSF)
05/18/2011	EP2322228A1 T cell receptor fusions and conjugates and methods of use thereof
05/18/2011	EP2322218A1 Methods of modulating CD200 receptors
05/18/2011	EP2322216A1 A preventive or therapeutic agent for sensitized T cell-mediated diseases comprising IL-6 antagonist as an active ingredient
05/18/2011	EP2322212A1 Compositon of antigen and glycolipid adjuvant for sublingual administration
05/18/2011	EP2322210A1 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
05/18/2011	EP2322209A2 Tumor specific oligosaccharide epitopes and use thereof
05/18/2011	EP2322185A2 Polynucleotide therapy
05/18/2011	EP2322165A1 Apo2 ligand/TRAIL formulations
05/18/2011	EP2322154A2 Methods for detecting and clearing cross beta structure comprising proteins with crossbeta structure binding compounds.
05/18/2011	EP2321351A2 Antibodies to ccr2
05/18/2011	EP2321318A1 Pyrazolopyridine kinase inhibitors
05/18/2011	EP2321284A1 Sulfone substituted quinazoline derivatives as immune-modulators for the treatment of inflammatory and allergic diseases
05/18/2011	EP2320916A2 Antihistamine and antihistamine-like nasal application, products, and method
05/18/2011	EP2320904A2 Aminopyrimidine inhibitors of histamine receptors for the treatment of disease
05/18/2011	EP2091949B1 Indole derivatives as s1p1 receptor agonists
05/18/2011	EP1966245B1 Anti-cd19 antibodies with reduced immunogenicity
05/18/2011	EP1268096B9 Extrusion die
05/18/2011	CN1982329B Biologically active peptide comprising tyrosyl-seryl-valine (YSV) and use thereof
05/18/2011	CN1874996B Aminopropanol derivatives
05/18/2011	CN1833543B Health beverage-'chenmei juice'
05/18/2011	CN1665554B Compounds and method for preparing surfaces in a haemocompatible manner
05/18/2011	CN102066557A Methods and compositions for accelerating the generation of regulatory T cells
05/18/2011	CN102066412A Treatment of diseases and conditions mediated by eicosanoids
05/18/2011	CN102066394A Analogues of glycolipids useful as immunoadjuvants
05/18/2011	CN102066377A Novel phenylimidazopyrazines
05/18/2011	CN102066372A 5,6-bicyclic heteroaryl-containing urea compounds as kinase inhibitors
05/18/2011	CN102065880A Immunotherapies employing self-assembling vaccines
05/18/2011	CN102065872A Probiotics to improve gut microbiota
05/18/2011	CN102065871A A novel composition of stem cells transplantation tolerance
05/18/2011	CN102065869A Antiallergic marine biopolymers
05/18/2011	CN102065867A Nutrition for prevention of infections
05/18/2011	CN102061322A Method for preparing polysaccharide, flavone and dietary fiber of peanut hulls in united manner

1 ... 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 ... 1172